Xenon Pharmaceuticals Stock Market Value
| XENE Stock | USD 42.63 0.52 1.21% |
| Symbol | Xenon |
Xenon Pharmaceuticals Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xenon Pharmaceuticals. If investors know Xenon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xenon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.81) | Quarterly Revenue Growth (1.00) | Return On Assets (0.19) | Return On Equity (0.27) |
The market value of Xenon Pharmaceuticals is measured differently than its book value, which is the value of Xenon that is recorded on the company's balance sheet. Investors also form their own opinion of Xenon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Xenon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xenon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Xenon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xenon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xenon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xenon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Xenon Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Xenon Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Xenon Pharmaceuticals.
| 06/04/2024 |
| 12/01/2024 |
If you would invest 0.00 in Xenon Pharmaceuticals on June 4, 2024 and sell it all today you would earn a total of 0.00 from holding Xenon Pharmaceuticals or generate 0.0% return on investment in Xenon Pharmaceuticals over 180 days. Xenon Pharmaceuticals is related to or competes with Nuvalent, Arcellx, Vaxcyte, Viridian Therapeutics, Crinetics Pharmaceuticals, Inhibrx, and Merus BV. Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat pati... More
Xenon Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Xenon Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Xenon Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.39 | |||
| Information Ratio | (0.01) | |||
| Maximum Drawdown | 9.29 | |||
| Value At Risk | (3.46) | |||
| Potential Upside | 3.72 |
Xenon Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Xenon Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Xenon Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Xenon Pharmaceuticals historical prices to predict the future Xenon Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0481 | |||
| Jensen Alpha | (0.06) | |||
| Total Risk Alpha | (0.25) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0801 |
Xenon Pharmaceuticals Backtested Returns
At this point, Xenon Pharmaceuticals is very steady. Xenon Pharmaceuticals shows Sharpe Ratio of 0.0541, which attests that the company had a 0.0541% return per unit of risk over the last 3 months. We have found thirty technical indicators for Xenon Pharmaceuticals, which you can use to evaluate the volatility of the company. Please check out Xenon Pharmaceuticals' Mean Deviation of 1.71, downside deviation of 2.39, and Market Risk Adjusted Performance of 0.0901 to validate if the risk estimate we provide is consistent with the expected return of 0.12%. Xenon Pharmaceuticals has a performance score of 4 on a scale of 0 to 100. The firm maintains a market beta of 1.32, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Xenon Pharmaceuticals will likely underperform. Xenon Pharmaceuticals right now maintains a risk of 2.15%. Please check out Xenon Pharmaceuticals maximum drawdown, accumulation distribution, relative strength index, as well as the relationship between the semi variance and day typical price , to decide if Xenon Pharmaceuticals will be following its historical returns.
Auto-correlation | 0.46 |
Average predictability
Xenon Pharmaceuticals has average predictability. Overlapping area represents the amount of predictability between Xenon Pharmaceuticals time series from 4th of June 2024 to 2nd of September 2024 and 2nd of September 2024 to 1st of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Xenon Pharmaceuticals price movement. The serial correlation of 0.46 indicates that about 46.0% of current Xenon Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.46 | |
| Spearman Rank Test | 0.34 | |
| Residual Average | 0.0 | |
| Price Variance | 3.33 |
Xenon Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Xenon Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Xenon Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Xenon Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Xenon Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Xenon Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Xenon Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Xenon Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Xenon Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Xenon Pharmaceuticals Lagged Returns
When evaluating Xenon Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Xenon Pharmaceuticals stock have on its future price. Xenon Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Xenon Pharmaceuticals autocorrelation shows the relationship between Xenon Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Xenon Pharmaceuticals.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Xenon Pharmaceuticals is a strong investment it is important to analyze Xenon Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Xenon Pharmaceuticals' future performance. For an informed investment choice regarding Xenon Stock, refer to the following important reports:Check out Xenon Pharmaceuticals Correlation, Xenon Pharmaceuticals Volatility and Xenon Pharmaceuticals Alpha and Beta module to complement your research on Xenon Pharmaceuticals. For information on how to trade Xenon Stock refer to our How to Trade Xenon Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Xenon Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.